Merrimack Pharmaceuticals, Inc. Forecast, price target & analysts
$15.13
0.00%
Nasdaq,
Mon, Jun 03 2024
Merrimack Pharmaceuticals, Inc. Target price 2024 - Analyst rating & recommendation
Powered by
Merrimack Pharmaceuticals, Inc. Classifications & Recommendation:
Hold
50%
Sell
50%
Merrimack Pharmaceuticals, Inc. Target price
| Target price | $4.00 |
| Course | $15.13 |
| Deviation |
73.56%
register free of charge
|
| Number of estimates | 1 |
|
1 Analyst has issued a Merrimack Pharmaceuticals, Inc. price target 2025.
The average Merrimack Pharmaceuticals, Inc. target price is $4.00.
This is
73.56%
register free of charge
|
|
| A rating was issued by 2 analysts: 0 Analysts recommend Merrimack Pharmaceuticals, Inc. to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst estimates: Analysts believe that the Merrimack Pharmaceuticals, Inc. share has an average upside potential 2025 of
73.56%
register free of charge
|
Discover more stocks with a high price target
Register for free
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.
